Regulatory dysfunction in leukotaxis.
The chemotactic factor inactivator (CFI) in human serum appears to have important regulatory function in the inflammatory response. In humans with elevated serum levels of CFI, defective mobilization of leukocytes in vivo has been noted, both in skin windows and in skin testing with various antigens. In experimental immune complex-induced acute inflammatory reactions in rat skin and lung, purified human CFI at very low doses has potent antiinflammatory effects and is able to suppress permeability changes, neutrophil infiltration, and hemorrhage, all of which are dependent initially on the role of leukotactic mediators.
D000818:Animals; D000936:Antigen-Antibody Complex; D001183:Arthus Reaction / Q000276:immunology; D002634:Chemotaxis, Leukocyte; D003165:Complement System Proteins; D006801:Humans; D007249:Inflammation / Q000276:immunology*; D007962:Leukocytes / Q000276:immunology; D008168:Lung / Q000276:immunology; D009504:Neutrophils / Q000276:immunology; D051381:Rats; D012867:Skin / Q000276:immunology; D012882:Skin Tests; D012884:Skin Window Technique
D000936:Antigen-Antibody Complex; D003165:Complement System Proteins